IEQ Capital’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.54M Sell
106,098
-23,971
-18% -$323K 0.01% 922
2026
Q1
$1.8M Buy
130,069
+20,402
+19% +$284K 0.01% 807
2025
Q4
$1.54M Buy
109,667
+424
+0.4% +$5.95K ﹤0.01% 884
2025
Q3
$1.53M Buy
109,243
+51,441
+89% +$740K ﹤0.01% 856
2025
Q2
$869K Buy
57,802
+41,362
+252% +$591K 0.01% 902
2025
Q1
$217K Sell
16,440
-4,313
-21% -$59.5K ﹤0.01% 1336
2024
Q4
$328K Buy
20,753
+1,703
+9% +$25.6K ﹤0.01% 992
2024
Q3
$303K Buy
19,050
+1,425
+8% +$22.9K ﹤0.01% 927
2024
Q2
$269K Buy
+17,625
New +$253K ﹤0.01% 831

Other funds holding RDY

IEQ Capital's RDY Position: Q2 2026 in Review

IEQ Capital reduced its Dr. Reddy's Laboratories (RDY) stake by 18% in Q2 2026, selling an estimated $323K and leaving 106,098 shares worth $1.54M. The position accounts for 0.01% of the portfolio, ranked #922.

IEQ Capital first reported a position in RDY in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.8M in Q1 2026. 239 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • IEQ Capital held 106,098 shares of Dr. Reddy's Laboratories worth $1.54M as of Q2 2026.
  • IEQ Capital sold 23,971 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $323K.
  • Dr. Reddy's Laboratories made up 0.01% of IEQ Capital's portfolio in Q2 2026, its #922 holding.
  • IEQ Capital first reported a position in Dr. Reddy's Laboratories in Q2 2024 and has held it in 9 quarters since.
  • IEQ Capital's Dr. Reddy's Laboratories position peaked at $1.8M in Q1 2026.
  • 239 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.